102 related articles for article (PubMed ID: 28288349)
1. Perivascular medical devices and drug delivery systems: Making the right choices.
Mylonaki I; Allémann É; Saucy F; Haefliger JA; Delie F; Jordan O
Biomaterials; 2017 Jun; 128():56-68. PubMed ID: 28288349
[TBL] [Abstract][Full Text] [Related]
2. A review on the treatment of intimal hyperplasia with perivascular medical devices: role of mechanical factors and drug release kinetics.
Raval AJ; Parikh JK; Desai MA
Expert Rev Med Devices; 2023; 20(10):805-819. PubMed ID: 37559556
[TBL] [Abstract][Full Text] [Related]
3. Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery.
Chaudhary MA; Guo LW; Shi X; Chen G; Gong S; Liu B; Kent KC
J Control Release; 2016 Jul; 233():174-80. PubMed ID: 27179635
[TBL] [Abstract][Full Text] [Related]
4. Highly flexible and porous silk fibroin microneedle wraps for perivascular drug delivery.
Lee J; Jang EH; Kim JH; Park S; Kang Y; Park S; Lee K; Kim JH; Youn YN; Ryu W
J Control Release; 2021 Dec; 340():125-135. PubMed ID: 34688718
[TBL] [Abstract][Full Text] [Related]
5. Transfer-molded wrappable microneedle meshes for perivascular drug delivery.
Lee J; Kim DH; Lee KJ; Seo IH; Park SH; Jang EH; Park Y; Youn YN; Ryu W
J Control Release; 2017 Dec; 268():237-246. PubMed ID: 29030224
[TBL] [Abstract][Full Text] [Related]
6. Drug clearance and arterial uptake after local perivascular delivery to the rat carotid artery.
Lovich MA; Brown L; Edelman ER
J Am Coll Cardiol; 1997 Jun; 29(7):1645-50. PubMed ID: 9180131
[TBL] [Abstract][Full Text] [Related]
7. Perivascular patch using biodegradable polymers: Investigation of mechanical and drug elution characteristics.
Raval AJ; Parikh JK; Desai MA
J Mech Behav Biomed Mater; 2023 Jun; 142():105853. PubMed ID: 37099919
[TBL] [Abstract][Full Text] [Related]
8. Perivascular biodegradable microneedle cuff for reduction of neointima formation after vascular injury.
Lee KJ; Park SH; Lee JY; Joo HC; Jang EH; Youn YN; Ryu W
J Control Release; 2014 Oct; 192():174-81. PubMed ID: 25025286
[TBL] [Abstract][Full Text] [Related]
9. Local drug delivery via transvascular injection.
Gonschior P; Backfisch G; Muth G; Schiele R; Vogel-Wiens C; Pahl C; Sponer G
J Invasive Cardiol; 1999 Oct; 11(10):600-7. PubMed ID: 10745441
[TBL] [Abstract][Full Text] [Related]
10. Sophisticated medical devices as local drug-delivery systems.
Schierholz JM; Beuth J
Med Device Technol; 2000 Mar; 11(2):12-4, 16-7. PubMed ID: 10915487
[TBL] [Abstract][Full Text] [Related]
11. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
Moon MC; Molnar K; Yau L; Zahradka P
J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
[TBL] [Abstract][Full Text] [Related]
12. Perivascular sirolimus-delivery system.
Filova E; Parizek M; Olsovska J; Kamenik Z; Brynda E; Riedel T; Vandrovcova M; Lisa V; Machova L; Skalsky I; Szarszoi O; Suchy T; Bacakova L
Int J Pharm; 2011 Feb; 404(1-2):94-101. PubMed ID: 21075185
[TBL] [Abstract][Full Text] [Related]
13. Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity.
Melhem M; Kelly B; Zhang J; Kasting G; Li J; Davis H; Heffelfinger S; Desai P; Roy-Chaudhury P
Blood Purif; 2006; 24(3):289-98. PubMed ID: 16465049
[TBL] [Abstract][Full Text] [Related]
14. Intelligent drug-delivery devices based on micro- and nano-technologies.
Chi AH; Clayton K; Burrow TJ; Lewis R; Luciano D; Alexis F; D'hers S; Elman NM
Ther Deliv; 2013 Jan; 4(1):77-94. PubMed ID: 23323782
[TBL] [Abstract][Full Text] [Related]
15. Sustained local drug delivery from a novel polymeric ring to inhibit intimal hyperplasia.
Kanjickal D; Lopina S; Evancho-Chapman MM; Schmidt S; Donovan D
J Biomed Mater Res A; 2010 May; 93(2):656-65. PubMed ID: 19610053
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-eluting medical devices for various applications.
Zilberman M; Elsner JJ
J Control Release; 2008 Sep; 130(3):202-15. PubMed ID: 18687500
[TBL] [Abstract][Full Text] [Related]
17. Bioadhesive Perivascular Microparticle-Gel Drug Delivery System for Intimal Hyperplasia Prevention: In Vitro Evaluation and Preliminary Biocompatibility Assessment.
Melnik T; Porcello A; Saucy F; Delie F; Jordan O
Gels; 2022 Nov; 8(12):. PubMed ID: 36547300
[TBL] [Abstract][Full Text] [Related]
18. Influence of cerebral blood vessel movements on the position of perivascular synapses.
Urrecha M; Romero I; DeFelipe J; Merchán-Pérez A
PLoS One; 2017; 12(2):e0172368. PubMed ID: 28199396
[TBL] [Abstract][Full Text] [Related]
19. Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia.
Kanjickal D; Lopina S; Evancho-Chapman MM; Schmidt S; Donovan D; Springhetti S
J Biomed Mater Res A; 2004 Mar; 68(3):489-95. PubMed ID: 14762928
[TBL] [Abstract][Full Text] [Related]
20. Shape-memory polymers as a technology platform for biomedical applications.
Lendlein A; Behl M; Hiebl B; Wischke C
Expert Rev Med Devices; 2010 May; 7(3):357-79. PubMed ID: 20420558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
